adc

Documents about adc

• ADC-induced Neurotoxicity Treated With Duloxetine#1431273ClinicalTrials.gov
• The "ADC-after-ADC" paradigm: navigating cross-resistance and sequencing in breast cancer therapy.#1134652NCBI PubMed Central
• 70CMSD25FC0000008 — ADC LTD NM — Department of Homeland Security ($31,211,931)#602104USAspending
• 70B06C24F00000442 — ADC LTD NM — Department of Homeland Security ($31,208,618)#602105USAspending
• 70B06C23F00000197 — ADC LTD NM — Department of Homeland Security ($28,351,294)#602235USAspending
• PET/CT for Trop2 ADC Response Evaluation Cancers#1372177ClinicalTrials.gov
• The IMPROVE Study-IMPact of a Regulated ADC System#1397699ClinicalTrials.gov
• Diffusion MRI (Magnetic Resonance Imaging) Using ADC (Apparent Diffusion Coefficient) Histograms in the Evaluation of Adnexal Tumor Aggressiveness#966709ClinicalTrials.gov
• New Frontiers in ADC Analysis: Advances in Chromatography, Electrophoresis, and Mass Spectrometry#1537798HAL (France)
• A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors#873618ClinicalTrials.gov
• A Phase 1 Study of BHV-1530 in Advanced Solid Tumors#991678ClinicalTrials.gov
• Eribulin Mesylate-based Therapy in Patients With Advanced HER2-negative Breast Cancer Previously Treated With ADC#1321859ClinicalTrials.gov
• ADC-1013 First-in-Human Study#411403ClinicalTrials.gov
• Disitamab Vedotin (RC48-ADC) in Breast Cancer#1421569ClinicalTrials.gov
• Convergent S318T substitution in ADC enzymes contributes to reduced meropenem susceptibility in epidemic IC2 Acinetobacter baumannii#1415200HAL (France)
• Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Chinese Participants With Solid Tumors#852709ClinicalTrials.gov
• A Study of FDA018-ADC in Patients With Advanced Solid Tumors#1383721ClinicalTrials.gov
• Readout ADC-based chain circuit trade-offs#640165bonndata Dataverse OAI Archive
• Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers#853918ClinicalTrials.gov
• A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer#1213705ClinicalTrials.gov
• HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer#1244242ClinicalTrials.gov
• A 4.06 mW 10-bit 150 MS/s SAR ADC with 1.5-bit/cycle operation for medical imaging applications#190061NTU Digital Repository
• A Phase 1 Study of DEM301 in Participants With Metastatic Colorectal Cancer#1246699ClinicalTrials.gov
• Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers#1485856ClinicalTrials.gov
• Spatial Multiomics Reveal Insights Into ADC Efficacy.#157918NCBI PubMed Central
• RC48-ADC in HER2-low Advanced Breast Cancer#804756ClinicalTrials.gov
• Fosrolapitant and Palonosetron for Highly Emetogenic ADC-Induced Nausea and Vomiting in Solid Tumors#1363455ClinicalTrials.gov
• Replication Data for: "Implementation of EC-RISM for ADC(2) and CC2 to Include Solvent Granularity Effects in Excited-State Energies and Gradients"#278177TUDOdata Dataverse OAI Archive
• Applying the Agent-Deed-Consequence (ADC) Model to Smart City Ethics#94868PhilArchive
• An Efficient Wireless iBCI Headstage with Adaptive ADC Sample Rate#126476arXiv CS
• Clinical Study on the Efficacy and Safety of RC48-ADC in the Treatment of Metastatic Castration Resistant Prostate Cancer (mCRPC)#855902ClinicalTrials.gov
• Clinical Value of DWI-ADC Matching in the Short-term Prognosis of Wilson's Disease#1214675ClinicalTrials.gov
• RC48-ADC in Combination With Gemcitabine in High Risk NMIBC Subjects#1477232ClinicalTrials.gov
• VLSI Spike Encoder for Spiking Neural Networks with 4-Bit SAR ADC#300454DigitalCommons@CalPoly
• ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer#906761ClinicalTrials.gov
• Automatic Dataset Construction (ADC): Sample Collection, Data Curation, and Beyond#152993arXiv (OAI)
• The DELPHI barrel electromagnetic calorimeter flash ADC based digitizer#159138CERN CDS
• An Open-label Extension Study of PSMA ADC 2301 in mCRPC#881201ClinicalTrials.gov
• A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors#1088847ClinicalTrials.gov
• Design and Implementation of a 0.2-V VCO-Based ADC for High-Sensitivity CDMS Instrumentation#300552DigitalCommons@USU
• A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases#846264ClinicalTrials.gov
• The Use of MRI Apparent Diffusion Coefficient Value (ADC Value) to Assess Liver Cirrhosis#1101187ClinicalTrials.gov
• A Timing-Robust Frequency-Interleaved ADC with Embedded Analog Fourier Transform#1187614arXiv (All)
• CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma#143557ClinicalTrials.gov
• Towards Reliable AI-Assisted Analog Design: Template-Constrained LLM Agents for SAR ADC Generation#373473arXiv CS
• Delay Line Based Adc And High Frequency Pulse Generation In Electrical Lc Latices#493524Cornell eCommons
• A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor#830535ClinicalTrials.gov
• The first IXPE view of the eclipsing ADC source 4U 1822-37#1076883arXiv (All)
• Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors#1195628ClinicalTrials.gov
• Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors#876209ClinicalTrials.gov